Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Anthony R Martin

10PUBLICATIONS
37CO-AUTHORS
Medical infection agents (incl. prions)Industrial molecular engineering of nucleic acids and proteinsMolecular targetsProteins and peptidesGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Apr 01, 2026
Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis.

Cécile Favreau, Maxence Bourgoin, Coline Savy

|Jan 22, 2026
Molecular engineering of lysosome-based degraders unveils a rapidly expanding therapeutic strategy.

Adele Rivault, Jade Dussart-Gautheret, Rachid Benhida

|Jan 14, 2026
EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge.

Christopher F Bassil, Kerry Dillon, Gray R Anderson

|Aug 30, 2025
Targeting pregnane X receptor with a potent agonist-based PROTAC to delay colon cancer relapse.

Lucile Bansard, Guillaume Laconde, Vanessa Delfosse

|May 30, 2024
Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule.

Lois M Kelly, Justine C Rutter, Kevin H Lin

|Jun 17, 2023
Covalent-reversible peptide-based protease inhibitors. Design, synthesis, and clinical success stories.

Anthony Feral, Anthony R Martin, Alexandre Desfoux

Pageof 2

Frequent Collaborators

2 joint publications

Guillaume Robert

2 joint publications

Alexandre Puissant

2 joint publications

Shane T Killarney

2 joint publications

Kris C Wood

1 joint publications

Arnaud Jacquel

1 joint publications

Mohsine Driowya

1 joint publications

Frédéric Luciano

1 joint publications

Stéphane Rocchi

1 joint publications

Anthony Feral

1 joint publications

Alexandre Desfoux

Frequent Collaborators

2 joint publications

Guillaume Robert

2 joint publications

Alexandre Puissant

2 joint publications

Shane T Killarney

2 joint publications

Kris C Wood

Top Related Videos

Revealing the Ferroptotic Phenotype of Medulloblastoma
04:01

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on : Mar 15, 2024

2.1K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on : Jan 04, 2015

11.2K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

9.2K
See more related videos

Top Related Videos

Revealing the Ferroptotic Phenotype of Medulloblastoma
04:01

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on : Mar 15, 2024

2.1K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on : Jan 04, 2015

11.2K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

9.2K
See more related videos